In-hospital Start of Sacubitril-Valsartan Cost-Effective in HFrEF In-hospital Start of Sacubitril-Valsartan Cost-Effective in HFrEF

Initiation of sacubitril-valsartan in acute HF is more clinically effective and cost-effective vs initiation in ambulatory HF. Full adoption of this strategy could save $92M yearly, researchers say.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news
More News: Cardiology | Diovan | Heart | Hospitals